Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Funding: This work was supported by National Natural Science Foundation of China (Grant No#: 81471026, to A.W.) and Diabetes Doctors Foundation of China (to A.W.)
Current services and referral pathways should be confirmed directly
This study enrolled adults with obesity (body mass index 30 kg/m) without type 2 diabetes, and a separate cohort with type 2 diabetes, across multiple international sites
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, whereas semaglutide only targets the GLP-1 receptors
The table below outlines what typically happens during daily use
US$ 25.82
US$ 24.81
US$ 25.94
